Sevcan Hatipoglu

Sevcan Hatipoglu

Auto-generated profile, based on publicly available information

Sevcan Hatipoglu

Faculty of Medicine, Department of Pediatric Nephrology Dokuz Eylül University İzmir Türkiye

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2026 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
NCNeslihan Cicek
Neslihan Cicek
CACeren Alavanda
Ceren Alavanda
APAyse Seda Pınarbası
Ayse Seda Pınarbası
AIAylin Inal
Aylin Inal
BABahriye Atmıs
Bahriye Atmıs
IGIbrahim Gokce
Ibrahim Gokce
Introduction: We aimed to evaluate the clinical and genetic characteristics and clinical course of children with persistent proteinuria associated with CUBN variants. Methods: Forty-eight children with CUBN variants from 15 pediatric nephrology centers were included. Patients’ characteristics, serum creatinine, albumin, hemoglobin, vitamin B12 levels, urinalysis, spot urine protein/creatinine (uPCR), microalbumin/creatinine (uACR), beta-2 microglobulin/creatinine (uBMCR) ratios, estimated glomerular filtration rates (eGFRs), treatments, kidney biopsies, and genetic findings were evaluated. Results: All patients had normal serum albumin and creatinine and preserved eGFR. There was no significant change in eGFR between the first and last visits ( p = 0.15), whereas uPCR was lower at the last visit ( p = 0.001). Kidney biopsy was performed in 13 (27%); light microscopy was normal in all except one patient with focal segmental glomerulosclerosis (FSGS). Thirty-five patients (72.9%) had ACEi/ARB therapy, which was discontinued in 21 patients without subsequent worsening of proteinuria. Overall, 26 distinct CUBN variants were identified, predominantly in the C-terminal region. The most frequent variant was c.10102A > G (p.Met3368Val). Variant types included 15 (57.7%) missense, 7 (27%) nonsense, 3 (11.5%) splicing, and 1 (3.8%) frameshift variants. Conclusions: In this multicenter, large pediatric cohort, proteinuria associated with CUBN variants generally followed a benign course over short to mid-term follow-up even without sustained ACEi/ARB therapy. Embedding targeted CUBN testing into the evaluation of children with asymptomatic proteinuria and normal kidney function may reduce unnecessary kidney biopsies and prolonged medication, while improving family counseling. We outline a stepwise care pathway → early genetic screening → conservative monitoring with periodic eGFR and proteinuria assessment → consideration of ACEi/ARB discontinuation and recommend prospective validation and cost-effectiveness studies.

5 April 2026 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
SYSerife Ozturk Yilmaz
Serife Ozturk Yilmaz
AYAyca Yigit
Ayca Yigit
SHSevcan Hatipoglu
Sevcan Hatipoglu
SGSemra Gürsoy
Semra Gürsoy
AGAytac Gulcu
Aytac Gulcu
OBOzlem Giray Bozkaya
Ozlem Giray Bozkaya

26 October 2026 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
SHSevcan Hatipoğlu
Sevcan Hatipoğlu
EYErkam Yıldırım
Erkam Yıldırım
ÖŞÖzge Yıldırım Şalbaş
Özge Yıldırım Şalbaş
KŞKadriye Cansu Şahin
Kadriye Cansu Şahin
GKGizem Kaygusuz
Gizem Kaygusuz
ASAlper Soylu
Alper Soylu
Objectives: Apparent mineralocorticoid excess (AME) syndrome is a rare monogenic disorder caused by loss-of-function variants in the HSD11B2 gene encoding 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). Deficient enzyme activity results in cortisol-mediated activation of the mineralocorticoid receptor, leading to low-renin hypertension. Because affected infants frequently present with polyuria and hypokalemic metabolic alkalosis, AME syndrome is often misdiagnosed as Bartter syndrome, resulting in significant diagnostic delay. Case presentation: A 13-month-old girl presented with polyuria, hypokalemic metabolic alkalosis, hypercalciuria, and failure to thrive and was initially managed as Bartter syndrome. During follow-up, persistent hypertension accompanied by markedly suppressed plasma renin activity and aldosterone levels prompted evaluation for monogenic hypertension. Urinary steroid analysis demonstrated a markedly reduced cortisone-to-cortisol ratio (0.02), consistent with 11β-HSD2 deficiency. Next-generation sequencing of the HSD11B2 gene identified a homozygous likely pathogenic splice-site variant, c.665-1G>A, confirming the diagnosis of AME syndrome. Treatment with spironolactone, amlodipine, potassium supplementation, and dietary salt restriction achieved blood pressure control and improved electrolyte abnormalities. Conclusions: AME syndrome should be included in the differential diagnosis of infants presenting with hypokalemic metabolic alkalosis and polyuria, particularly when hypertension is detected. Systematic blood pressure assessment is essential in this clinical context, as early recognition of this monogenic disorder may prevent long-term cardiovascular and renal complications.